Evaluation of an [(18)F]AlF-NOTA Analog of Exendin-4 for Imaging of GLP-1 Receptor in Insulinoma - Wikidata - awgldk - TriplyDB

Evaluation of an [(18)F]AlF-NOTA Analog of Exendin-4 for Imaging of GLP-1 Receptor in Insulinoma

Evaluation of an [(18)F]AlF-NOTA Analog of Exendin-4 for Imaging of GLP-1 Receptor in Insulinoma

http://www.wikidata.org/entity/Q36383709

about

Advancement in treatment and diagnosis of pancreatic cancer with radiopharmaceuticals Imaging pancreatic islet cells by positron emission tomography GLP-1R-targeting magnetic nanoparticles for pancreatic islet imaging.One-pot two-step radiosynthesis of a new (18)F-labeled thiol reactive prosthetic group and its conjugate for insulinoma imaging Stability analysis of glutamic acid linked peptides coupled to NOTA through different chemical linkages.Fluorine-18 radiochemistry, labeling strategies and synthetic routes Dosimetry of [(68)Ga]Ga-DO3A-VS-Cys(40)-Exendin-4 in rodents, pigs, non-human primates and human - repeated scanning in human is possible Radiofluorination using aluminum-fluoride (Al18F)Development of a new thiol site-specific prosthetic group and its conjugation with [Cys(40)]-exendin-4 for in vivo targeting of insulinomas.Glucagon-Like Peptide-1 Receptor PET/CT with 68Ga-NOTA-Exendin-4 for Detecting Localized Insulinoma: A Prospective Cohort Study.Targets and probes for non-invasive imaging of β-cells.Current Status of Radiopharmaceuticals for the Theranostics of Neuroendocrine Neoplasms.Al(18) F labeling of peptides and proteins.Molecular imaging probes derived from natural peptides.Preliminary evaluation of [18F]AlF-NOTA-MAL-Cys39-exendin-4 in insulinoma with PET.(64)Cu labeled sarcophagine exendin-4 for microPET imaging of glucagon like peptide-1 receptor expression.Pilot study of a novel (18)F-labeled FSHR probe for tumor imaging.Beta cell specific probing with fluorescent exendin-4 is progressively reduced in type 2 diabetic mouse models.Al18F-Labeling Of Heat-Sensitive Biomolecules for Positron Emission Tomography Imaging.Preliminary biological evaluation of 18F-AlF-NOTA-MAL-Cys-Annexin V as a novel apoptosis imaging agent.Low kidney uptake of GLP-1R-targeting, beta cell-specific PET tracer, 18F-labeled [Nle14,Lys40]exendin-4 analog, shows promise for clinical imaging.PET Imaging of FSHR Expression in Tumors with 68Ga-Labeled FSH1 Peptide.Translational Molecular Imaging of Diabetes

P2860

Q26766690-0F0F4812-FB26-4ED8-89A8-42D5737A5D30 Q28075496-17ADEB7A-D253-43E3-9012-B694361C478F Q30588445-529BAE24-4E04-41B0-BE96-38C7CB3268CB Q34473707-A1DE1691-A3F5-4F87-A19F-6FFA523AA2A7 Q34473713-4A1D0647-5571-4D82-8011-D086E2571114 Q35013514-7FAFD147-7907-458A-B757-58C032AE38A5 Q35656591-29718B04-E5A4-4528-BE5F-95850ACF6168 Q36880744-7B155E8A-6C94-4F56-92FF-7A6DA5B2795F Q37188818-01E1C5F7-D8B8-4F80-BB71-7112314FC9AB Q37581371-C96CF4D5-A588-468A-B592-4D0F3C995D43 Q37662672-C2305533-2AE3-4662-90F9-937B5AC748B0 Q37731335-6E88E368-606C-433B-8F86-6C57D40D6F10 Q38177202-287BE0F1-E674-4412-B31D-3BC1F356FAB1 Q38748846-17D0A872-034F-48ED-AE03-D338C888EF79 Q38901439-CE759982-D967-46E6-892F-9C49524234D4 Q38982109-FEBAB8BF-3699-4DB5-8AC5-7F45AD2B330D Q39037392-65DEACD4-C1BA-43E7-B887-E261985A1472 Q39932172-2A128B59-5C99-4982-8EBB-0F46F1E40C0A Q41455532-671CB97F-69A5-456B-ACFE-99F50396B0C9 Q41612624-A72263D2-4A42-4201-B319-442834DC9658 Q41860402-ACECDE9C-B763-4049-8463-8052F3D6E8C0 Q43376016-2ED32B7B-3266-4FB5-81C8-1F9A187B2819 Q58630430-B157643D-2643-4610-A61B-1ACFFAB1B1CD

P2860

Evaluation of an [(18)F]AlF-NOTA Analog of Exendin-4 for Imaging of GLP-1 Receptor in Insulinoma

http://www.wikidata.org/entity/Q36383709

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Evaluation of an [(18)F]AlF-NO ...... f GLP-1 Receptor in Insulinoma

@ast

Evaluation of an [(18)F]AlF-NO ...... f GLP-1 Receptor in Insulinoma

@en

type

label

Evaluation of an [(18)F]AlF-NO ...... f GLP-1 Receptor in Insulinoma

@ast

Evaluation of an [(18)F]AlF-NO ...... f GLP-1 Receptor in Insulinoma

@en

prefLabel

Evaluation of an [(18)F]AlF-NO ...... f GLP-1 Receptor in Insulinoma

@ast

Evaluation of an [(18)F]AlF-NO ...... f GLP-1 Receptor in Insulinoma

@en

P1433

Q36383709-F030E995-CECC-4F4E-9546-5A1EA1B0C581

P1476

Q36383709-1BDD4304-93EA-49E4-ABB4-78F68D30B0FC

P2093

Q36383709-351135DB-8EAA-4906-B579-04FABC3CA58F

Q36383709-49656E11-D18E-4B06-BB80-049E1278B108

Q36383709-D65CF6B5-F2ED-47C3-B5C3-42BA2C27B23A

Q36383709-D6719CF2-6DD0-440B-A7EA-4E6954518171

Q36383709-D715E60C-8F71-4F46-B1C6-36528867BD06

P2860

Q36383709-0BD8643A-E225-45A2-9778-0D1E7D3D41F5

Q36383709-3B3F233D-F696-4171-91F1-E86464F0E036

Q36383709-3C7C34AD-14A1-4D36-B6CA-E74F80175808

Q36383709-451C5C8E-B866-41FF-A606-70D1EFFEF7B2

Q36383709-47102631-B47F-4506-8605-4FC6EE115325

Q36383709-4CAF1592-01C6-448C-8016-3E7463626BDC

Q36383709-59912E93-BD4A-4F27-A165-641C59EA694A

Q36383709-5E1D3403-7F43-47FE-A3CE-2A2D6CE5B8CC

Q36383709-615791C8-B2CC-4A77-AD90-04DF47D57D72

Q36383709-632B7EAF-665B-42E5-B67B-277FA945055E

P304

Q36383709-6EBB9B1D-569B-4A94-B298-B441FBD02BE7

P31

Q36383709-C44DEF5A-2094-4A62-8CC4-72E623CD9BD3

P356

Q36383709-A7AD8A66-85B2-463E-90A0-D9407C7FBAAF

P433

Q36383709-CC71FBBA-1EA5-4D12-88D8-D7A39CA5F028

P478

Q36383709-9AFE2E68-8F6D-4864-8156-120457F0D45F

P50

Q36383709-20281FD8-3D67-4A40-BB88-5BF0FE40FA9D

Q36383709-767065EA-FAAE-4540-B16B-2F4D3FFD3BC6

Q36383709-CEDB7A6B-6CC2-4567-9FFB-D92C459D30DA

P577

Q36383709-AB80F197-BA64-42B1-B388-7B5B97A794AD

P5875

Q36383709-16525C4E-7E8A-4CE7-A804-88ED503CAD9A

P698

Q36383709-0380F7FE-050F-4955-87B7-91B7F7294FCE

P932

Q36383709-DDF7077B-668F-4DD6-861A-CB8E3A47B283

P356

P1433

P1476

Evaluation of an [(18)F]AlF-NO ...... f GLP-1 Receptor in Insulinoma

@en

P2093

Haokao Gao

http://www.w3.org/2001/XMLSchema#string

Jinxia Guo

http://www.w3.org/2001/XMLSchema#string

Lei Zhu

http://www.w3.org/2001/XMLSchema#string

Ning Guo

http://www.w3.org/2001/XMLSchema#string

Ying Ma

http://www.w3.org/2001/XMLSchema#string

P2860

Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo

Standardized methods for the production of high specific-activity zirconium-89.

68Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET.

(18)F, (64)Cu, and (68)Ga labeled RGD-bombesin heterodimeric peptides for PET imaging of breast cancer.

Improved 18F labeling of peptides with a fluoride-aluminum-chelate complex

(68)Ga-labeled DOTA-peptides and (68)Ga-labeled radiopharmaceuticals for positron emission tomography: current status of research, clinical applications, and future perspectives.

Automated radiochemical synthesis of [18F]FBEM: a thiol reactive synthon for radiofluorination of peptides and proteins.

Concomitant expression of several peptide receptors in neuroendocrine tumours: molecular basis for in vivo multireceptor tumour targeting.

PET of insulinoma using ¹⁸F-FBEM-EM3106B, a new GLP-1 analogue

Pharmacology of exenatide (synthetic exendin-4): a potential therapeutic for improved glycemic control of type 2 diabetes.

P304

999-1009

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7150/THNO.5276

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

Dale O Kiesewetter

P577

2012-10-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233385535

http://www.w3.org/2001/XMLSchema#string

P698

23139727

http://www.w3.org/2001/XMLSchema#string

P932

3493201

http://www.w3.org/2001/XMLSchema#string